市場調査レポート
商品コード
1090136
眼内インプラントの世界市場規模:製品・用途・エンドユース・地域別の予測(2022年~2028年)Global Ocular Implants Market Size study, by Product by Application by End-use and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
眼内インプラントの世界市場規模:製品・用途・エンドユース・地域別の予測(2022年~2028年) |
出版日: 2022年06月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の眼内インプラントの市場規模は、2021年に約141億5,000万米ドルと評価され、予測期間である2022年~2028年には5.8%を超える健全な成長率で拡大すると予測されています。
加齢黄斑変性、白内障、緑内障、強膜炎など、目の病気の発症頻度の増加が同市場を牽引すると予想されます。発症率の上昇に伴い、眼内インプラントを必要とする外科的処置の需要も高まっています。また、市場拡大を牽引する要素として、老年人口の増加、糖尿病発症率の上昇、座りっぱなしの生活習慣、技術的進歩が挙げられます。しかし、2022年~2028年の予測期間において、市場の成長はインプラントの高いコストによって阻害されるでしょう。
当レポートでは、世界の眼内インプラント市場を調査し、市場の概要、業界分析、COVID-19によるリスク評価、製品・用途・エンドユース・地域別の分析、および競合情報などを提供しています。
List of figures
Global Ocular Implants Market is valued approximately USD 14.15 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.8% over the forecast period 2022-2028. An intraocular lens implant is a synthetic, artificial lens that is implanted inside the eye to replace the focusing power of a natural lens that has been surgically removed, most commonly during cataract surgery. The market is expected to be driven by an increase in the frequency of eye illnesses such as age-related macular degeneration, cataract, glaucoma, and scleritis. As the rate of occurrence rises, so does the demand for surgical procedures that require ocular implants. According to the United States National Library of Medicine study, based on previous trends in cataract procedures, 3.7 million cataract surgeries are expected to be done among Medicare beneficiaries in the United States in 2020. Age-related disorders include cataracts and age-related macular degeneration in the eyes. Another element driving the market's expansion is an increase in the geriatric population. Additionally, the increased incidence of diabetes and the increasing adoption of a sedentary lifestyle may lead to diabetic retinopathy, which is expected to raise ocular implant sales. According to the International Diabetes Federation, around 537 million people had diabetes in 2021, and this number is expected to climb to 643 million by 2030. Another major aspect driving market expansion is technological advancement. The emergence of micro-invasive glaucoma devices for glaucoma sufferers is a typical example of technology progress in recent years. Glaukos Corporation, for example, got FDA approval in June 2018 for its iStent Inject second-generation trabecular meshwork bypass stent. The device is approved for use during phacoemulsification and is suggested for the treatment of mild to moderate glaucoma. However, over the projection period of 2022-2028, the market's growth would be hampered by the high cost of implants.
The key regions considered for the global Ocular Implants Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America led the market. The rising frequency of eye problems, sedentary lifestyles, and key players' increased focus on launching products in North America are all contributing to the region's market expansion. A good reimbursement scenario and the availability of technologically advanced items in the region are some factors that are likely to keep the region in the lead during the projection period. During the projection period, the Asia Pacific market is predicted to grow at the fastest rate. Due to a large increase in the geriatric population, developing countries such as China and India are likely to have the highest growth in Asia Pacific. According to China's seventh population census, the country's population aged 60 and more accounted for 18.7% of the overall population in 2020. Other factors driving market expansion include an increase in the diabetic population, an increase in cataract procedures, and rising personal and government spending on eye care.
Major market player included in this report are:
Alcon, Inc.,
Bausch & Lomb, Inc.
Carl Zeiss AG
Johnson & Johnson
STAAR Surgical Company
Morcher GmbH
Hoya Corporation
Glaukos Corporation
Second Sight
Allergan
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Intraocular Lens
Corneal Implants
Orbital Implants
Glaucoma Implants
Ocular Prosthesis
Others
By Application
Glaucoma Surgery
Oculoplasty
Drug Delivery
Age-related Macular Degeneration
Aesthetic Purpose
By End-use
Hospitals
Specialty Eye Institutes
Clinics
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Ocular Implants Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors